Flu Vaccine Falls Short as New Virus Strikes

The United States’ flu season is winding down, but this year’s vaccine delivered lower protection than expected.

Key Statistics

• Adult Protection: Only 25 %–30 % of adults were spared medical care.
• Child Hospital Visits: Vaccine cut hospital visits by ~40 %.
• Effectiveness Threshold: Successful vaccines typically reach 40 %–60 % effectiveness; this year ranks near the bottom of a two‑decade trend.

Why It Fell Short

• Mismatched Strain: The dominant virus, A H3N2 subclade K, spread widely early in winter.
• Vaccine Design: The vaccine targeted a different H3N2 version, creating a mismatch that reduced its impact.
• Disease Severity: The new strain spread more easily but did not cause noticeably worse illness.

Impact Across the Nation

• New York City reported the strongest season in two decades.
• Children: 101 deaths this season, ~85 % of which involved unvaccinated children.

Vaccination Coverage

• Adults: 46.5 % received a flu shot (slightly above last year).
• Children: 48 % vaccinated by late February.
• Both rates are below the 52 % rate seen in 2024, likely worsening the season.

Looking Ahead

Even with a mismatch, vaccines still reduce severe disease. Scientists are already developing next season’s formulations. The World Health Organization recommends that the 2026‑27 vaccines include protection against subclade K.